The FDA Making Treatment Safe for “Chemical Imbalances” That Don’...
by Robbie

The FDA Making Treatment Safe for “Chemical Imbalances” That Don’t Exist    17 y  
This is my first blog but I felt it was an important subject seeing as so many people need to be educated about the monopoly that's being played on us by these powerful forces.So here it is.
 
June 28, 2005 Expressing concern about “psychiatric risks”, the U.S. Food and Drug Administration (FDA) intends to change the warnings for drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD). The drugs they refer to are amphetamine-like, Schedule II products: Concerta, Ritalin, Adderall (an amphetamine banned in Canada but not the US) and Strattera. The psychiatric side effects mentioned in the FDA’s release, “FDA: Concerned With Psychiatric Risks With ADHD Drugs,” are “visual hallucinations, suicidal ideation, psychotic behavior, as well as aggression or violent behav ...   read more



 
 

Add Blog To Your Favorites!

This article was just sent to me from my friends @ the Safe Harbor organization. And they wonder wht Tom Cruise was so angry, I am too! more...

Last Activity: 17 y ago
1 Messages   Last message 17 y ago
0 Comments   Last comment 17 y ago

viewed 14,051 times
Created: 17 y   Jul 06 2005

Similar Blogs (10 of 185):
Learning to manage …  by CynthiaMadison  44 d
The Life Skills Eve…  by rosiedunn  46 d
Benefits of Best Mo…  by howerpharma  57 d
5 Kids Activities f…  by PaisleyH  3 mon
Coping with Lonelin…  by CynthiaMadison  8 mon
Sleeping Disorder  by Rimsha  10 mon
The Health Center  by jakeriv132  11 mon
The effect of music…  by guestmember  12 mon
The Development of …  by iStellaLinco  12 mon
The Mental Health R…  by matarch90  15 mon
All Blogs (1,019)


Lugol’s Iodine Free S&H
J.Crow’s® Lugol’s Iodine Solution. Restore lost reserves.



Wormwood Parasites Cleanse
Hulda Clark Cleanses



CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2022  curezone.org

10.032 sec, (2)